NIH Trial Shows Promising Results in Treating a Lymphoma in Young People
Friday, April 12, 2013
Studies demonstrate that the use of rituximab in the drug regimen may improve treatment.
Scientists Develop World's Smallest Drug Deliverer
Friday, April 12, 2013
Cornell researchers have created a pore in “Cornell Dots” – brightly glowing nanoparticles nicknamed C-Dots – that can carry medicine.
Scientists Map Cancer-, Aging-Related Enzyme
Friday, April 12, 2013
Researchers have solved the puzzle of how the various components of an entire telomerase enzyme complex fit together and function in a three-dimensional structure.
Algeta Elects New Non-executive Members
Friday, April 12, 2013
Hilde Furberg and Paolo Pucci elected as new members of Algeta’s Board of Directors.
Aprea Presents Preclinical Data at AACR
Thursday, April 11, 2013
Strong synergistic effect with APR-246 and cisplatin.
BioLineRx Receives Regulatory Approval to Commence Phase II Clinical Trial for BL-8040
Thursday, April 11, 2013
Final results expected in H2 2014.
Early Results of Activartis AV0113 Cancer Immunotherapy in Glioblastoma Trial Reveal Promising Trend
Thursday, April 11, 2013
Glioblastoma multiforme (GBM) is the most severe form of brain cancer and progresses rapidly.
Affymetrix and BioDiscovery Announce Software for Analysis of Whole Genome Copy Number Data
Thursday, April 11, 2013
Generated from FFPE solid tumor samples for accelerating cancer translational research.
ARIAD Presents Data for Investigational Inhibitor
Thursday, April 11, 2013
New preclinical data showing AP26113 inhibits clinically relevant mutants of ALK and ROS1.
|
|
|
|
|
|
